Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.72 USD | +1.60% | -3.20% | -37.06% |
May. 29 | Sector Update: Health Care Stocks Lean Lower Premarket Wednesday | MT |
May. 29 | Cytek Biosciences Gets Approval for Clinical Use of TBNK Reagents in China | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.28% | 739M | |
+7.21% | 217B | |
+12.39% | 190B | |
+19.84% | 143B | |
+30.29% | 111B | |
+1.33% | 64.59B | |
+16.01% | 52.36B | |
-0.16% | 48.45B | |
-5.30% | 38.03B | |
+0.16% | 35.6B |
- Stock Market
- Equities
- CTKB Stock
- News Cytek Biosciences, Inc.
- Piper Sandler Adjusts Price Target on Cytek Biosciences to $8.50 From $10, Maintains Overweight Rating